"Mark Butler has a mammoth task, now that he has responsibility for the NDIS, but he has committed to HTA reform. There is an opportunity for him to be more directive to officials, which is something we might need," said Medicines Australia chief executive Liz de Somer.
'I think we have to step up and help him to understand that he's got to deliver on it'
May 22, 2025 Latest NewsBioPharmaBioPharmaDispatch ExecutiveNews of the Day
Latest Video
New Stories
-
Mark Butler starts the process of NDIS pricing reform
June 11, 2025 - - Latest News -
Pfizer chief sets out the potential implications of 'Most Favored Nation' pricing
June 11, 2025 - - Latest News -
What will the HTA Review Implementation Advisory Group do if the PBAC rejects the process?
June 11, 2025 - - Latest News -
Advocacy group 'pleading' with the NSW Government to establish Men B vaccine program
June 10, 2025 - - Latest News -
New study reveals superior efficacy of cell-based flu vaccine
June 10, 2025 - - Latest News -
Medicines Australia says delayed listings would not be a surprising response
June 10, 2025 - - Latest News -
Companies confirm renewed push for streamlined immunotherapy listing process
June 9, 2025 - - Latest News